SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus.
Accelerated atherosclerotic vascular disease (ASVD) is a major cause of death in systemic lupus erythematosus (SLE). Although many authorities are calling for aggressive assessment and management of cardiac risk factors in patients with SLE, both theoretical and practical barriers to this approach exist. It seems that SLE and/or its treatment are themselves strong risk factors for the development of ASVD and it is unclear how much this risk can be decreased by the control of traditional risk factors. Studies from several centers have shown that suboptimal risk factor management and barriers to acceptance of these measures must also be studied further.
Costenbader
Karen H
KH
The Robert B, Brigham Arthritis and Musculoskeletal Disease Clinical Research Center, Brigham and Women's Hospital, Boston, Massachusetts, USA. kcostenbader@partners.org
Liang
Matthew H
MH
D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control*; D018450:Disease Progression; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D012307:Risk Factors